JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES)

• Articles • Previous Articles     Next Articles

Medication intervention on heme oxygenase/carbon monoxide and nitric oxide synthase/nitric oxide systems in the atherosclerosis model of rabbits

LIU Tong-tao1, YU Qing-xia2, TIAN Qing-yin1, SUN Chun-li1, LI Bo-qin3   

  1. 1. Department of Cardiology, Qilu Hospital of Shangdong University, Jinan 250012, China;2. Department of ICU, Yantai Yuhuangding Hospital, Yantai 264000, Shandong China; 3. Institute of Histology and Embryology
  • Received:2007-11-27 Revised:1900-01-01 Online:2008-06-16 Published:2008-06-16
  • Contact: LIU Tong-tao

Abstract: To investigate changes and intercorrelation of heme oxygenase-1(HO-1)/carbon monoxide(CO) and nitric oxide synthase (NOS)/nitric oxide(NO) and the effect of simvastatin on them in atherosclerotic progress. Methods16 rabbits had a 1% cholesterol diet for eight weeks and after eight weeks were fed with normal diets for eight weeks and then were divided into two groups: the simvastatin group and the model group, 8 rats fed with normal diets served as the control group. Levels of serum lipids, serum NO and plasma CO were determined at the beginning, the 8th week and the 16th week, and also the expressions of HO-1 and NOS in the thoracia aortic tissues were determined by the immunohistochemistry technique. ResultsAt the end of the 8th week, levels of serum lipids and plasma CO were increased in the simvastatin group (P<0.01) and the level of serum NO and expressions of HO-1 and inducible nitric oxide synthase (iNOS) were decreased compared with the control group (P<0.01). At the end of the 16th week, levels of serum lipids and plasma CO and expressions of HO-1 and iNOS were significantly decreased (P<0.01), with the model group. Conclusions In atherosclerotic progress, HO1/CO and NOS/NO systems have a reciprocal relationship, and simvastatin may delay the atherosclerotic progress by decreasing the two systems.

Key words: Atherosclerosis, Heme oxygenase, Carbon monoxide, Nitric oxide synthase, Nitric oxide, Simvastatin, Immunohistochemistry

CLC Number: 

  • R541.4
[1] GAO Xiu-Rui, ZANG Heng-Chang. In vitro release of compound niacin extended-release and simvastatin immediaterelease double-layer tablets [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 109-113.
[2] DUAN Yingzhu, DONG Bo, YU Rui. Mendelian randomization study on the association of intrinsic emotions with coronary atherosclerosis risk in patients with rheumatoid arthritis [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 63-71.
[3] LI Xiping, QIU Mei, HUANG Ruifeng, LIN Huihui, LIU Sisi, LUO Hongying, WANG Yuyue, WANG Min, YANG Xiaotong. Research progress on the mechanism of berberines anti-atherosclerosis effects based on the synergistic effect of lipid deposition inhibition and metabolic clearance [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 77-83.
[4] CAO Luofei, WANG Shanshan, WANG Jinrong, JIANG Heyun, MIAO Yu, MA Guangzeng. Analysis of the characteristics of bronchial dilation test in children with FeNO elevation during asthma exacerbation [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 38-44.
[5] ZHANG Rugang, YIN Yue, LI Daiyun, DUAN Mengqi, LIU Guilian, WANG Ying. Impact of Mycoplasma infection on pulmonary function and fractional exhaled nitric oxide in adults [J]. Journal of Shandong University (Health Sciences), 2025, 63(3): 71-75.
[6] DU Aijia, ZHANG Man, CHEN He, WANG Lixin, SHANG Yingshu. miR-1270-targeted regulation of angiopoietin-like protein 7 inhibits macrophage inflammation and lipid accumulation [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 1-9.
[7] WEI Yanruoxue, LI Ziqi, LIU Chuncheng, LIU Xiaohan, ZHAO Ran, LIU Yukun. Intratumor heterogeneity of SP1 expression in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 89-94.
[8] LIU Chuncheng, LIU Xiaohan, WEI Yanruoxue, LI Ziqi, LIU Yukun, ZHAO Ran. Subcellular localization pattern of bromodomain containing 9 in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 24-30.
[9] WU Lin, SHI Chenxi, TONG Xing. Pulmonary benign metastasizing leiomyoma: a report of 7 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 78-84.
[10] FAN Rong, LI Binbin, MA Xiaoli, WANG Yunshan, JIA Yanfei. Expressions and clinical significance of DEC2 and HIF-2α in gastric cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(7): 12-18.
[11] XU Tianqi, CHANG Na, ZHANG Shuai, LI Sha, JIAO Bingxuan, YU Xinxin, WANG Ximing. Identification of carotid high-risk plaques by non-alcoholic fatty liver disease based on CTA [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 36-43.
[12] WU Hong, ZHANG Zhengduo, TANG Yanjin, QI Shaojun, GAO Xibao. Potential intervention effects of 5-methyltetrahydrofolate on atherosclerosis in rats [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 6-13.
[13] XIE Jiaying, QI Jia, SONG Ming, LI Yulin, WANG Di, JIA Xu, ZHANG Wei, ZHONG Ming, SHANG Yuanyuan. Association between serum β-sheet level and coronary heart disease [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 21-26.
[14] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24-31.
[15] HE Pengjuan, YAN Lei, FAN Mingjun, LIU Xiangbin, ZHAO Xingbo. Effects of simvastatin on TGF-β induced epithelial-to-mesenchymal transition in ovarian cancer [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 46-51.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!